Electrocore Inc (ECOR) Stock Price, Quote & News

Company Profile

electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also deve...

Industry: Medical Devices

Sector: Healthcare

Phone: 973 290 0097

Fax: 973 290 9171

Website: www.electrocore.com

Address:

200 Forge Way, Suite 205, Rockaway, United States

Citten Jun. 20 at 7:38 PM

$ECOR catalyst for that pa?

0 · Reply

Wickedkiwi Jun. 20 at 2:39 PM

$ECOR holy volatility 😅

0 · Reply

taxplanr Jun. 13 at 4:13 PM

$ECOR fibromyalgia is a really nice category to be in with drug free treatments combined with science on social channels

0 · Reply

10baggerPete Jun. 10 at 9:23 PM

$ECOR the Core problem her is that the stock's leg got peed on and it's regrouping, could take time but should emerge stimulated and ready to tackle the vagus nerves of the multitudes.

0 · Reply

iAccess_Alpha Jun. 10 at 7:02 PM

Update: electroCore Inc. $ECOR will no longer be presenting at iAccess Alpha’s Virtual Best Ideas Summer Conference on June 24, 2025. We hope to host them at a future event. #microcap #smallcap #investing

1 · Reply

Alidrisi Jun. 8 at 8:51 PM

$ECOR

0 · Reply

JoeReno Jun. 6 at 1:47 PM

$ECOR Unsustainable business model. Growth requires either constant share dilution or constant cash flow reinvestment.

0 · Reply

taxplanr Jun. 6 at 12:55 PM

$ECOR caught a Chinese whale https://investor.electrocore.com/node/11586/html

1 · Reply

FinJay May. 30 at 7:47 PM

$ECOR https://youtu.be/_uqCk7v0znQ

0 · Reply

FJBCADCAM May. 30 at 4:39 AM

$ECOR after she does reverse cowgirl

1 · Reply

electroCore, Inc. (ECOR) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 6 weeks ago

electroCore Announces First Quarter 2025 Financial Results

May 2, 2025, 8:00 AM EDT - 7 weeks ago

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies

May 1, 2025, 8:00 AM EDT - 7 weeks ago

electroCore's Truvaga™ Now Works with the Apple Health app

Apr 30, 2025, 8:00 AM EDT - 2 months ago

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

Apr 17, 2025, 8:00 AM EDT - 2 months ago

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

Apr 16, 2025, 8:00 AM EDT - 2 months ago

electroCore to Participate at the Planet MicroCap Showcase

Apr 3, 2025, 8:00 AM EDT - 2 months ago

electroCore Named One of The Americas' Fastest Growing Companies by the Financial Times

Apr 1, 2025, 8:00 AM EDT - 3 months ago

electroCore to Participate at the Needham Virtual Healthcare Conference

Mar 31, 2025, 8:00 AM EDT - 3 months ago

electroCore Extends VA Contract for Five Years

Mar 12, 2025, 9:36 PM EDT - 3 months ago

electroCore, Inc. (ECOR) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 4:05 PM EDT - 3 months ago

electroCore Announces Full Year 2024 Financial Results

Mar 6, 2025, 8:00 AM EST - 3 months ago

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025

Mar 5, 2025, 8:00 AM EST - 4 months ago

electroCore to Participate at Upcoming Investor Conferences

Feb 27, 2025, 8:00 AM EST - 4 months ago

electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal

Feb 4, 2025, 8:00 AM EST - 5 months ago

electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 14, 2025, 10:17 AM EST - 5 months ago

electroCore: An Opportunity In Medical And Wellness Device Innovation

Dec 30, 2024, 1:59 PM EST - 6 months ago

electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM

Dec 17, 2024, 4:05 PM EST - 6 months ago

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

Nov 14, 2024, 8:00 AM EST - 7 months ago

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

Nov 13, 2024, 9:18 PM EST - 7 months ago

electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 7 months ago

electroCore Announces Third Quarter 2024 Financial Results

Nov 12, 2024, 4:01 PM EST - 8 months ago

ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award

Nov 8, 2024, 4:01 PM EST - 8 months ago

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Oct 14, 2024, 8:00 AM EDT - 9 months ago

electroCore to Participate at LD Micro Main Event VXII

Sep 10, 2024, 8:00 AM EDT - 10 months ago

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

Sep 4, 2024, 8:00 AM EDT - 10 months ago

electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 10, 2024, 4:27 AM EDT - 11 months ago

electroCore, Inc. (ECOR) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 8:00 AM EDT - 11 months ago

electroCore to Participate in Upcoming Investor Conferences

Aug 7, 2024, 4:01 PM EDT - 11 months ago

electroCore Announces Second Quarter 2024 Financial Results

Jun 25, 2024, 8:00 AM EDT - 1 year ago

electroCore Announces the Commercial Launch of TAC-STIM™

Jun 3, 2024, 8:30 AM EDT - 1 year ago

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

May 8, 2024, 10:19 PM EDT - 1 year ago

electroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:05 PM EDT - 1 year ago

electroCore Announces First Quarter 2024 Financial Results

May 1, 2024, 8:04 AM EDT - 1 year ago

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion

Apr 8, 2024, 8:30 AM EDT - 1 year ago

electroCore Announces the Launch of Truvaga Plus® for General Wellness

Apr 2, 2024, 8:00 AM EDT - 1 year ago

electroCore Expands Intellectual Property Portfolio

Mar 13, 2024, 8:15 PM EDT - 1 year ago

electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 4:05 PM EDT - 1 year ago

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

Mar 5, 2024, 4:05 PM EST - 1 year ago

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024

Dec 12, 2023, 8:00 AM EST - 1 year ago

electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology

Nov 15, 2023, 8:15 AM EST - 1 year ago

Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023

Nov 8, 2023, 10:27 PM EST - 1 year ago

electroCore, Inc. (ECOR) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:01 PM EST - 1 year ago

electroCore Announces Third Quarter 2023 Financial Results

Nov 7, 2023, 8:00 AM EST - 1 year ago

electroCore to Participate in Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum

Oct 24, 2023, 8:00 AM EDT - 1 year ago

Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting

Oct 17, 2023, 8:00 AM EDT - 1 year ago

electroCore Announces Two-Year Extension of gammaCore™ Device Listing in the NHS Supply Chain Catalogue

Oct 11, 2023, 8:00 AM EDT - 1 year ago

electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology

Oct 10, 2023, 8:00 AM EDT - 1 year ago

Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress

Citten Jun. 20 at 7:38 PM

$ECOR catalyst for that pa?

0 · Reply

Wickedkiwi Jun. 20 at 2:39 PM

$ECOR holy volatility 😅

0 · Reply

taxplanr Jun. 13 at 4:13 PM

$ECOR fibromyalgia is a really nice category to be in with drug free treatments combined with science on social channels

0 · Reply

10baggerPete Jun. 10 at 9:23 PM

$ECOR the Core problem her is that the stock's leg got peed on and it's regrouping, could take time but should emerge stimulated and ready to tackle the vagus nerves of the multitudes.

0 · Reply

iAccess_Alpha Jun. 10 at 7:02 PM

1 · Reply

Alidrisi Jun. 8 at 8:51 PM

$ECOR

0 · Reply

JoeReno Jun. 6 at 1:47 PM

$ECOR Unsustainable business model. Growth requires either constant share dilution or constant cash flow reinvestment.

0 · Reply

taxplanr Jun. 6 at 12:55 PM

$ECOR caught a Chinese whale https://investor.electrocore.com/node/11586/html

1 · Reply

FinJay May. 30 at 7:47 PM

$ECOR https://youtu.be/_uqCk7v0znQ

0 · Reply

FJBCADCAM May. 30 at 4:39 AM

$ECOR after she does reverse cowgirl

1 · Reply

taxplanr May. 27 at 2:10 PM

$ECOR director purchases shares https://investor.electrocore.com/node/11581/html

0 · Reply

iAccess_Alpha May. 27 at 1:05 PM

electroCore Inc. $ECOR will present at iAccess Alpha’s Virtual Best Ideas Summer Conference. June 24, 2025 | 12:00 PM ET Watch here: https://www.webcaster4.com/Webcast/Page/3118/52508 #microcap #smallcap #investing

0 · Reply

FinJay May. 23 at 3:52 AM

$ECOR https://youtu.be/_uqCk7v0znQ

0 · Reply

taxplanr May. 20 at 4:09 PM

TikTok users who #autoimmunedisease really appreciate finding out about the science on the $ECOR website I also like to let them know Truvaga Plus works as a handhled muscle massager for back neck shoulder sciatica pain and more don't forget the #vagusnerve either https://www.electrocore.com/medical-affairs/publications/

0 · Reply

stick_to_stocks May. 20 at 6:06 AM

$ECOR this has popped few times on my scanner during last days Could be short covering, but I will keep an eye

0 · Reply

inspector_gadget86 May. 19 at 9:03 PM

$ECOR Reports Q1 Loss, Misses Revenue Estimates

1 · Reply

taxplanr May. 19 at 9:00 PM

I find my $ECOR Truvaga Plus does wonders for low back pain hip neck shoulder etc

0 · Reply

Mudloaf May. 16 at 5:39 PM

$ECOR bottomed

0 · Reply

FJBCADCAM May. 16 at 3:55 PM

$ECOR looks like shorts were chasing

0 · Reply

10baggerPete May. 15 at 11:20 PM

$ECOR i expect this to rally tomorrow based on how wrong a certain someone was on Tssi.

1 · Reply

Mnpois May. 15 at 5:54 PM

$ECOR won’t generics beat this

2 · Reply

Shareholdersunite May. 15 at 1:02 PM

$ECOR Could it be that Q4/24 was just a blip in an otherwise relentless growth at the VA as the gammaCore is back on track in Q1/25 and now joined in with Truvaga growth.. https://shareholdersunite.substack.com/p/a-quick-take-on-electrocore

1 · Reply

Market Cap	38.07M
Revenue (ttm)	25.18M
Net Income (ttm)	-11.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-47.22%
Debt to Equity Ratio	0.00

Volume	91,600
Avg Vol	122,468
Day's Range	N/A - N/A
Shares Out	7.42M
Stochastic %K	47%
Beta	0.79
Analysts	Strong Sell
Price Target	$21.10